Skip to main content
Clinical Trials/SLCTR/2015/003
SLCTR/2015/003
Withdrawn
未知

Randomized controlled trial on the effectiveness of montelukast in reducing symptoms and hospital stay in children with acute bronchiolitis aged 3 to 18 months

Department of Paediatrics0 sites92 target enrollmentTBD
ConditionsBronchiolitis

Overview

Phase
未知
Intervention
Not specified
Conditions
Bronchiolitis
Sponsor
Department of Paediatrics
Enrollment
92
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Children between 3 months and 18 months with clinical features which are considered in making a diagnosis of bronchiolitis such as prodromal fever, rhinorrhoea and cough
  • 2\. At least 2 of the following signs on admission: chest retractions, tachypnoea, wheezing

Exclusion Criteria

  • 1\. Symptoms lasting for more than 5 days before admission
  • 2\. Previous history of wheezing
  • 3\. Underlying chronic diseases eg. cardiac disease

Outcomes

Primary Outcomes

Not specified

Similar Trials